Pierre Sirois is born in December 12, 1945 in Quebec, QC, Canada. He graduated with a B.A. degree, Laval University, Quebec, QC, Canada, B.S. degree in biochemistry, and M.S. and Ph.D. degrees in pharmacology, University of Sherbrooke, QC, Canada. He spent three years of postdoctoral studies at Royal College of Surgeons of England, Imperial College of Science and Technology of London, and the Hospital for Sick Children of Toronto in pharmacology and immunology completed his education. He joined the University of Sherbrooke Medical School in 1978 and has been promoted as a Full Professor and the Chair of Pharmacology in 1987. He trained a number of pharmacologists, founded the Institute of Pharmacology of Sherbrooke, and created two biotechnology companies: IPS Pharma Inc. (neuropathic pain) and IPS Therapeutique Inc. (cardiotoxicity of NCEs). His research interests are focused on pulmonary pharmacology (asthma and inflammatory reactions). He played a major role in the structure characterization and pharmacology of SRS-A and leukotrienes. His research is supported by various agencies including the MRC Canada now called Canadian Institutes of Health Research, the Fonds de la recherche en santé du Québec, and the Heart and Stroke Foundation. He authored more than 330 publications and 530 abstracts and has delivered more than 300 lectures in various countries. He has been a Scholar of the MRC Canada and Fonds de la recherche en santé du Québec for many years. He also received selected awards including MRC Scientist Award and was named Knight of L’Ordre de la Pléiade from Quebec Government. He has been a member of numerous university and national committees and on the boards of a few companies and associations. He is an executive editor of an international journal and on the editorial board of many others.
Biography Updated on 18 May 2015